VVUS VIVUS Inc.

3.57
-0.08  -2%
Previous Close 3.65
Open 3.61
Price To Book -0.95
Market Cap 37974675
Shares 10,637,164
Volume 27,043
Short Ratio
Av. Daily Volume 79,755

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved July 17, 2012.
Qnexa
Obesity
Approved Apr 27 2012. sNDA label change also approved 17 Sept 2014
Avanafil
Erectile dysfunction
Phase 1 trial completed July 2018.
VI-0106
Pulmonary arterial hypertension (PAH)

Latest News

  1. VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019
  2. VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction
  3. Edited Transcript of VVUS earnings conference call or presentation 26-Feb-19 9:30pm GMT
  4. VIVUS Reports Fourth Quarter 2018 Financial Results
  5. VIVUS to Host Fourth Quarter and Full Year Business Update and Financial Results Conference Call on Tuesday, February 26, 2019
  6. 3 Biotech Stocks That Pay Solid Dividends
  7. VIVUS Announces Date of 2019 Annual Meeting
  8. Today's Research Reports on Trending Tickers: Array BioPharma and VIVUS
  9. Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism
  10. VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster
  11. VIVUS to Present at Biotech Showcase on January 9, 2019
  12. Do Institutions Own Shares In VIVUS, Inc. (NASDAQ:VVUS)?
  13. 5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride
  14. The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
  15. Vivus (VVUS) Down 17% Since Last Earnings Report: Can It Rebound?
  16. New Research Coverage Highlights CommVault, Dawson Geophysical, RF Industries, Hennessy Advisors, VIVUS, and Semiconductor Manufacturing International — Consolidated Revenues, Company Growth, and Expectations for 2018
  17. Edited Transcript of VVUS earnings conference call or presentation 1-Nov-18 8:30pm GMT
  18. VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y
  19. Vivus: 3Q Earnings Snapshot
  20. VIVUS Reports Third Quarter 2018 Financial Results